Aktiespot

Northeast Pharmaceutical Group Co., Ltd. (NORTHEAST PHARMACEUTICAL GROUP) aksje

000597.SZ

Stengt
¥4.4400+0.0100 (+0.23%)
Laster graf...

NORTHEAST PHARMACEUTICAL GROUP

Åpning4.5900
Høy4.4900
Lav4.4100
Volum10.56M
P/E26.12
Markedsverdi6.34B
52-ukers høy6.6800
52-ukers lav4.4100
Gj.sn. volum16.39M
Utbytte2.25%
Beta0.06
EPS0.1700

Om Northeast Pharmaceutical Group Co., Ltd. (NORTHEAST PHARMACEUTICAL GROUP) aksje

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals manufacturing, pharmaceutical distribution, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti- infective products, such as fosfomycin series, azithromycin series, amantadine series, polyalkali hydrochloride, chloramphenicol, and other products; and reproductive system and hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. It also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and psychotropic drugs and related products, including morphine hydrochloride injections and tablets, oxycodone hydrochloride injection, compound glycyrrhiza series, and acetaminophen-codeine tablets; anti-AIDS products comprising Krughar /zidovudine tablets and capsules, efavirenz tablets, and other products; and in vitro biological diagnostic reagent products for HIV, HBV, HCV, HPV, and TB. In addition, it offers general health products, including glucosamine sulfate chondroitin collagen D3 calcium capsules, protein powder, probiotic powder, effervescent tablets, chewable tablets, solid drinks, and other products. Further, it provides Enterogermina, magnesium aluminum carbonate chewable tablets; compound proglutamine-cimetidine tablets; acetaminophen tablets; pain relievers, phenacetin, pregabalin, noscapine syrup, and citrate table; and other products, as well as cell therapy products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

Selskapsinformasjon

Børs: Shenzhen (SHZ)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
No. 8, Kunming Street
110027 Shenyang, China
Telefon: + 86 24 2580 6963

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: